Ignite Creation Date:
2024-10-25 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06645275
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-14
Brief Title:
Point-of-Care Testing POCT for Guided Precision Anticoagulation With Warfarin A Multicenter Non-concurrent Controlled Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Point-of-Care Testing POCT for Guided Precision Anticoagulation With Warfarin A Multicenter Non-concurrent Controlled Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to compare the key clinical indicators such as the time to achieve INR target frequency of dose adjustment and the incidence of thrombotic and hemorrhagic events between Point-of-Care Testing POCT and pyrosequencing technology in the precision dosing of warfarin in order to assess whether POCT-based warfarin genetic testing is beneficial for improving the quality of anticoagulation treatment for patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None